Peak Expiratory Flow Rate (PEFR)-A Simple Ventilatory Lung Function Test
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Maximum Expiratory Flow Rates in Induced Bronchoconstriction in Man
Maximum expiratory flow rates in induced bronchoconstriction in man A. Bouhuys, … , B. M. Kim, A. Zapletal J Clin Invest. 1969;48(6):1159-1168. https://doi.org/10.1172/JCI106073. Research Article We evaluated changes of maximum expiratory flow-volume (MEFV) curves and of partial expiratory flow-volume (PEFV) curves caused by bronchoconstrictor drugs and dust, and compared these to the reverse changes induced by a bronchodilator drug in previously bronchoconstricted subjects. Measurements of maximum flow at constant lung inflation (i.e. liters thoracic gas volume) showed larger changes, both after constriction and after dilation, than measurements of peak expiratory flow rate, 1 sec forced expiratory volume and the slope of the effort-independent portion of MEFV curves. Changes of flow rates on PEFV curves (made after inspiration to mid-vital capacity) were usually larger than those of flow rates on MEFV curves (made after inspiration to total lung capacity). The decreased maximum flow rates after constrictor agents are not caused by changes in lung static recoil force and are attributed to narrowing of small airways, i.e., airways which are uncompressed during forced expirations. Changes of maximum expiratory flow rates at constant lung inflation (e.g. 60% of the control total lung capacity) provide an objective and sensitive measurement of changes in airway caliber which remains valid if total lung capacity is altered during treatment. Find the latest version: https://jci.me/106073/pdf Maximum Expiratory Flow Rates in Induced Bronchoconstriction in Man A. Bouiuys, V. R. HuNTr, B. M. Kim, and A. ZAPLETAL From the John B. Pierce Foundation Laboratory and the Yale University School of Medicine, New Haven, Connecticut 06510 A B S T R A C T We evaluated changes of maximum ex- rates are best studied as a function of lung volume. -
Peak Flow Measure: an Index of Respiratory Function?
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Peak Flow Measure: An Index of Respiratory Function? D. Devadiga, Aiswarya Liz Varghese, J. Bhat, P. Baliga, J. Pahwa Department of Audiology and Speech Language Pathology, Kasturba Medical College (A Unit of Manipal University), Mangalore -575001 Corresponding Author: Aiswarya Liz Varghese Received: 06/12/2014 Revised: 26/12/2014 Accepted: 05/01/2015 ABSTRACT Aerodynamic analysis is interpreted as a reflection of the valving activity of the larynx. It involves measuring changes in air volume, flow and pressure which indicate respiratory function. These measures help in determining the important aspects of lung function. Peak expiratory flow rate is a widely used respiratory measure and is an effective measure of effort dependent airflow. Aim: The aim of the current study was to study the peak flow as an aerodynamic measure in healthy normal individuals Method: The study group was divided into two groups with n= 60(30 males and 30 females) in the age range of 18-22 years. The peak flow was measured using Aerophone II (Voice Function Analyser). The anthropometric measurements such as height, weight and Body Mass Index was calculated for all the participants. Results: The peak airflow was higher in females as compared to that of males. It was also observed that the peak air flow rate was correlating well with height and weight in males. Conclusions: Speech language pathologist should consider peak expiratory airflow, a short sharp exhalation rate as a part of routine aerodynamic evaluation which is easier as compared to the otherwise commonly used measure, the vital capacity. -
Introduction to Airway Resistance Measurements
Introduction to airway resistance measurements Dr. David Kaminsky Department of Medicine The University of Vermont VT 05405 Burlington UNITED STATES OF AMERICA [email protected] AIMS Review physiology of airway resistance Survey measures of airway resistance Provide examples of clinical applications Highlight research applications SUMMARY Airway resistance (Raw) is one of the fundamental features of the mechanics of the respiratory system. While the flow-volume loop offers insight into the volume and flow of air, it is limited in terms of specific information regarding lung mechanics. Airway resistance is the ratio of driving pressure divided by flow through the airways. It specifies the pressure required to achieve a flow of air with a velocity of 1L/sec. If the airway is represented by a simple, rigid tube, with laminar flow of air through it, the airway resistance Raw = (8 x L x )/ r4, where L = length of the tube, = viscosity of the gas, and r = radius of the tube. It is important to note that the r4 relationship demonstrates how sensitive resistance is to the size of the tube, varying inversely with the 4th power of the radius. The inner diameter of the airway is itself determined by many factors, including airway smooth muscle contractile state, airway wall thickness (related to inflammation, edema and remodeling), airway wall buckling and formation of mucosal folds, the interdependence, or linkage, of airway and surrounding lung parenchyma, and the intrinsic elastic recoil of the lung parenchyma, which serves as a load on the airway and variably resists bronchoconstriction. Of course, the airways are not rigid tubes, and in fact flow is a complex process involving both laminar and turbulent conditions, so this calculation of Raw is an approximation only. -
Spirometry Basics
SPIROMETRY BASICS ROSEMARY STINSON MSN, CRNP THE CHILDREN’S HOSPITAL OF PHILADELPHIA DIVISION OF ALLERGY AND IMMUNOLOGY PORTABLE COMPUTERIZED SPIROMETRY WITH BUILT IN INCENTIVES WHAT IS SPIROMETRY? Use to obtain objective measures of lung function Physiological test that measures how an individual inhales or exhales volume of air Primary signal measured–volume or flow Essentially measures airflow into and out of the lungs Invaluable screening tool for respiratory health compared to BP screening CV health Gold standard for diagnosing and measuring airway obstruction. ATS, 2005 SPIROMETRY AND ASTHMA At initial assessment After treatment initiated and symptoms and PEF have stabilized During periods of progressive or prolonged asthma control At least every 1-2 years: more frequently depending on response to therapy WHY NECESSARY? o To evaluate symptoms, signs or abnormal laboratory tests o To measure the effect of disease on pulmonary function o To screen individuals at risk of having pulmonary disease o To assess pre-operative risk o To assess prognosis o To assess health status before beginning strenuous physical activity programs ATS, 2005 SPIROMETRY VERSUS PEAK FLOW Recommended over peak flow meter measurements in clinician’s office. Variability in predicted PEF reference values. Many different brands PEF meters. Peak Flow is NOT a diagnostic tool. Helpful for monitoring control. EPR 3, 2007 WHY MEASURE? o Some patients are “poor perceivers.” o Perception of obstruction variable and spirometry reveals obstruction more severe. o Family members “underestimate” severity of symptoms. o Objective assessment of degree of airflow obstruction. o Pulmonary function measures don’t always correlate with symptoms. o Comprehensive assessment of asthma. -
Association of Cystic Fibrosis Withallergy
Arch Dis Child: first published as 10.1136/adc.51.7.507 on 1 July 1976. Downloaded from Archives of Disease in Childhood, 1976, 51, 507. Association of cystic fibrosis with allergy J. 0. WARNER, B. W. TAYLOR, A. P. NORMAN, and J. F. SOOTHILL From the Hospital for Sick Children, London Warner, J. O., Taylor, B. W., Norman, A. P., and Soothill, J. F. (1976). Archives of Disease in Childhood, 51, 507. Association of cystic fibrosis with allergy. Immediate skin hypersensitivity to various inhalant allergens was present in 59°% of 123 children with cystic fibrosis (CF), a much higher percentage than in the general population. This is consistent with the idea that atopy arises as a result of impaired handling of antigen at mucosal surfaces. The allergic CF children had more chest infections, a worse chest x-ray appearance, and lower peak expiratory flow rates. Allergic diseases were also frequent in the CF obligate heterozygotes (32% of mothers and 26 % of fathers). It is suggested that the heterozygotes may also have a mucosal abnormality resulting in defective antigen handling. The suggestion that atopy may result from exces- TABLE I sive stimulation of the IgE-producing cells because Clinical presentation of 123 children at initial of failure of antigen exclusion at mucosal surfaces diagnosis of cystic fibrosis related to subsequent skin- is supported by the observation that much infantile test findings atopy is preceded by IgA deficiency (Taylor et al., 1973). This is consistent with the view that anti- Skin test gen exclusion is, in part, dependent on immune Presentation Total reactions. -
Asthma Guidelines
ASTHMA CLINICAL PRACTICE GUIDELINES INITIAL CARE Assess ABCs Consider Alternative Diagnoses ■ Airway ■ Bronchiolitis (especially under age 2) ■ Breathing ■ Pneumonia ■ Circulation ■ Foreign body ■ Cardiac disease or congestive heart failure Initial Triage Options ■ Congenital airway abnormalities ■ Emergency Department or Outpatient Management ■ Immune deficiency/mucociliary defect ■ Admission to Inpatient Unit ■ Cystic fibrosis ■ Stabilize and transfer emergently to PICU based on clinical judgment and factors such as: Asthma: • Intubation, or severe compromise in patient previously ■ Episodic symptoms of airflow obstruction including intubated for asthma wheezing, cough, or chest tightness • Worsening on maximal medical therapy ■ Airflow obstruction at least partially reversible • Evidence for impending respiratory failure ■ Exclusion of alternative diagnoses • Complex co-existing or co-morbid conditions EXCLUSION CRITERIA ■ Age under 2 years ■ Alternative diagnosis (see above) ■ Severe distress or requiring PICU Care ASTHMA EXACERBATION CLASSIFICATION Mild Exacerbation Severe Exacerbation ■ Patient is alert and oriented, speaks in sentences, no ■ Patient is breathless at rest, speaks in words. Patient is using accessory muscle use, may have slight expiratory wheeze, accessory muscles, has suprasternal retractions, may have and is tachypneic. loud wheezing (throughout inhalation and exhalation), and ■ Peak flow >80% of predicted or personal best is tachypneic. (see background information for age norms) ■ Peak flow <50 % of predicted -
Peak Flow Monitoring Page 1 of 3
UTMB RESPIRATORY CARE SERVICES Policy 7.3.14 PROCEDURE - Peak Flow Monitoring Page 1 of 3 Peak Flow Monitoring Effective: 10/19/94 Formulated: 05/93 Revised: 04/04/18 Peak Flow Monitoring Purpose To quantify the efficacy of bronchodilator therapy in patients with limited or restricted expiratory flow rates. Scope Accountability/Special Training May be administered by a Licensed Respiratory Care Practitioner. Training must be equivalent to the minimal Therapist entry level in Respiratory Care Services with age specific recognition of requirements of population treated. Physician's A physician's order is required for peak flow meter measurements Order Peak flow monitoring is an integral part of bronchodilator therapy when ordered by a physician Indications Patients with limited or severely restricted expiratory flow. Patients on Bronchodilator Therapy. Patient is able to understand and physically able to attempt the test. Goals To monitor progression of the patients condition. Monitor drug efficacy. Improve dosing accuracy of MDI/Bronchodilator therapy. Contra- Patient does not have a level of comprehension that enables them to do indications the test. Patient will not cooperate. Patient has a facial condition or neurological condition that alters their ability to do the test. Patient distress level is such that attempting would only deteriorate their condition. Equipment Peak flow meter Procedure Step Action 1 Check physician's orders. 2 Obtains peak flow device. 3 Wash hands thoroughly. 4 Verifies patient by two identifiers 5 Explain Peak Flow monitoring to patient. Continued next page UTMB RESPIRATORY CARE SERVICES Policy 7.3.14 PROCEDURE - Peak Flow Monitoring Page 2 of 3 Peak Flow Monitoring Effective: 10/19/94 Formulated: 05/93 Revised: 04/04/18 Procedure Continued 6 Make sure the indicator is at the bottom of the scale. -
Role of the Allergist-Immunologist and Upper Airway Allergy in Sleep-Disordered Breathing
AAAAI Work Group Report Role of the Allergist-Immunologist and Upper Airway Allergy in Sleep-Disordered Breathing Dennis Shusterman, MD, MPHa, Fuad M. Baroody, MDb, Timothy Craig, DOc, Samuel Friedlander, MDd, Talal Nsouli, MDe, and Bernard Silverman, MD, MPHf; on behalf of the American Academy of Allergy, Asthma & Immunology’s Rhinitis, Rhinosinusitis and Ocular Allergy Committee Work Group on Rhinitis and Sleep-disordered Breathing San Francisco, Calif; Chicago, Ill; Hershey, Pa; Solon, Ohio; Washington, DC; and Brooklyn, NY BACKGROUND: Sleep-disordered breathing in general and RESULTS: Survey results were returned by 339 of 4881 active obstructive sleep apnea in particular are commonly encountered members (7%). More than two-third of respondents routinely conditions in allergy practice. Physiologically, nasal (or asked about sleep problems, believed that sleep-disordered nasopharyngeal) obstruction from rhinitis, nasal polyposis, or breathing was a problem for at least a “substantial minority” adenotonsillar hypertrophy are credible contributors to snoring (10%-30%) of their adult patients, and believed that medical and nocturnal respiratory obstructive events. Nevertheless, therapy for upper airway inflammatory conditions could existing practice parameters largely relegate the role of the potentially help ameliorate sleep-related complaints. Literature allergist to adjunctive treatment in cases of continuous positive review supported the connection between high-grade nasal airway pressure intolerance. congestion/adenotonsillar hypertrophy and obstructive sleep OBJECTIVES: To survey active American Academy of Allergy, apnea, and at least in the case of pediatric patients, supported the Asthma & Immunology members regarding their perceptions use of anti-inflammatory medication in the initial management and practices concerning sleep-disordered breathing in adult and of obstructive sleep apnea of mild-to-moderate severity. -
Dynamic Mechanics of the Lung Answer to the Last Class’S Question
Dynamic mechanics of the lung Answer to the Last class’s question Resistive (Frictional Forces) Opposing Lung Inflation Frictional opposition occurs only when the system is in motion. Frictional opposition to ventilation has the two components: 1. tissue viscous resistance 2. airway resistance. Tissue Viscous Resistance: the impedance of motion (opposition to flow) caused by displacement of tissues during ventilation that includes the lungs, rib cage, diaphragm, and abdominal organs. The frictional resistance is generated by the movement of each organ surface sliding against the other (e.g., the lung lobes sliding against each other and against the chest wall). Tissue resistance accounts for only approximately 20% of the total resistance to lung inflation. In conditions : obesity, pleural fibrosis, and ascites, the tissue viscous resistance increases the total impedance to ventilation. Airway Resistance (flow resistance) - Resistance to ventilation by the movement of gas through the airways. • accounts for approximately 80% of the frictional resistance to ventilation. • -is usually expressed in units of cm H2O/L/sec: R= ∆P/ ∆V • Airway resistance in healthy adults ranges from approximately 0.5 to 2.5 cm H2O/L/sec. • To cause gas to flow into or out of the lungs at 1 L/sec, a healthy person needs to lower his alveolar pressure 0.5 to 2.5 cm H2O below atmospheric pressure. Measurement of Airway Resistance • Airway resistance is the pressure difference between the alveoli and the mouth divided by a flow rate. Mouth pressure is easily measured with a manometer. Alveolar pressure can be deduced from measurements made in a body plethysmograph. -
Normative Data of Peak Expiratory Flow Rate in Healthy School Children Of
Research Article Normative data of peak expiratory flow rate in healthy school children of Ghaziabad city—a pilot study Rinku Garg1, Sharmila Anand2, Ravi Kant Sehgal3, Hari Pal Singh3 1Department of Physiology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. 2Department of Pharmacology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. 3Department of Community Medicine, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. Correspondence to: Rinku Garg, E-mail: [email protected] Received March 6, 2015. Accepted May 12, 2015 || ABSTRACT Background: Age, sex, weight, and height are the main factors that affect peak expiratory flow rate (PEFR). Various authors have shown that geographical, climatic, anthropometric, nutritional, and socioeconomic conditions of India are associated with regional differences in lung function. Aims and Objective: To establish the normative data of PEFR among school children aged 10–14 years in Ghaziabad city, Uttar Pradesh, India. Materials and Methods: A cross-sectional study was done in 500 school children aged 10–14 years in Ghaziabad city. PEFR was recorded with the Mini-Wright Peak Flow Meter. Anthropometric variables such as age, height, weight, and body mass index were recorded. Results were analyzed by ANOVA with SPSS, version 17.0, using unpaired t test. Result: Results showed that there was an increase in PEFR in boys and girls with an increase in age, height, and weight. Conclusion: Normative data of this study can be useful for the -
The Respiratory System - 3 Pressure Changes and Resistance
The Respiratory System - 3 Pressure changes and resistance Jennifer Carbrey Ph.D. Department of Cell Biology image by OCAL, http://www.clker.com/clipart-26501.html, public domain Respiratory System 1. Anatomy and mechanics 2. Lung volumes and compliance 3. Pressure changes and resistance 4. Pulmonary function tests and alveolar ventilation 5. Oxygen transport 6. CO2 transport and V/Q mismatch 7. Regulation of breathing 8. Exercise and hypoxia Respiratory System pleural sac: inner layer covers lungs outer layer is attached to chest wall fluid in between image by OCAL (modified), http://www.clker.com/clipart-12109.html, public domain Pressure & Lung Volumes PA Lungs P Intrapleural fluid ip Chest wall Patm = 0 mm Hg = 760 mm Hg Pressure & Lung Volumes PA Pip = -3 PA – Pip determines lung size and PA - Patm determines air flow Pressure & Lung Volumes end of expiration during expiration PA= +1 PA=0 Pip = -4 Pip = -3 during inspiration end of inspiration PA – Pip determines lung size and PA=0 PA= -1 PA - Patm determines air flow F = (PA- Patm) /R Pip = -5 Pip = -6 P1V1=P2V2 – Boyles Law Resistance & Air Flow F = (PA- Patm) /R Factors that influence resistance: 1. Airway diameter – the smaller the diameter the more resistance in that tube in lung, more tubes as you go further into lung - so combined resistance gets lower as enter lung 2. Lung volume – if have a greater lung volume then airways are not as compressed – can be a compensation to lung disease with increased resistance 3. Muscle tone – parasympathetic stimulation causes bronchiolar smooth muscle to contract; sympathetic stimulation causes relaxation 4. -
Peak Expiratory Flow Rate Assessment to Screen for Asthma in Children with Allergic Rhinitis
International Journal of Contemporary Pediatrics Krithika AP et al. Int J Contemp Pediatr. 2018 Nov;5(6):2278-2283 http://www.ijpediatrics.com pISSN 2349-3283 | eISSN 2349-3291 DOI: http://dx.doi.org/10.18203 /2349-3291.ijcp20184296 Original Research Article Peak expiratory flow rate assessment to screen for asthma in children with allergic rhinitis Krithika A. P.*, Arunkumar T., Sundari S. Department of Paediatrics, Sree Balaji Medical College and Hospital, Tamil Nadu, India Received: 02 September 2018 Accepted: 27 September 2018 *Correspondence: Dr. Krithika A. P., E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Allergic rhinitis is a common disease affecting around 10-25% of the population worldwide. There is a temporal relationship between the onset of allergic rhinitis and asthma and the ‘unified airway hypothesis’ explains this. Many researchers have demonstrated bronchial hyper-responsiveness prior to onset of asthma symptoms further validating this hypothesis. Further many studies favour treating allergic rhinitis may prevent the onset of asthma. So, detecting allergic rhinitis earlier and treating it adequately is of vital importance. The aims and objectives of this study is to identify bronchial hyper responsiveness in children with allergic rhinitis, prior to the onset of asthmatic symptoms, by measuring PEFR and its clinical correlates. Methods: A prospective observational study was conducted in Department of Paediatrics in Sree Balaji Medical College and Hospital.